Inc. develops ethical pharmaceuticals from purified extracts of plants and other
natural products that have been employed in traditional Chinese medicine for
more than 4,000 years. Drug efficacy is validated by clinical trials that
conform to the standards of the appropriate government regulatory agency. Our
company is currently focused on developing anticancer therapies, treatments for
cancer therapy-related bone-marrow suppression, and treatments for managing
transplant rejection. Our drugs will be commercialized initially in the
high-growth markets of China and Taiwan. The first pharmaceutical product
will enter the Chinese market in 2004.
Pharmagenesis, Inc. was founded in 1991
through the vision of Mr. Tih-Wu Wang. Mr. Wang, an entrepreneur who
created and built a very successful international communications empire,
believed that the pharmacopoeia of plants used in Traditional Chinese Medicine (TCM)
or Asian medicines held significant therapeutic potential as modern
pharmaceuticals if the conceptual differences in scientific theory between Asian
and Western medicines could be transcended and become complementary to one
Through studying the information recorded by TCM practitioners over four
millennia and applying a focused, methodical approach to the discovery and
development of potential drug candidates, Pharmagenesis has fulfilled Mr.
mission is to create value-added products based on the bioactive Natural
Products found in Traditional Chinese Medicines.
Our Facility in Palo Alto, California, USA
Pharmagenesis has a research and development facility in Palo Alto, CA as well
as operations in Beijing, Taipei and Paris.